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Background: Neurofibromatosis type 1 (NF1) is a relatively common autosomal dominant disorder. The most
common vascular abnormality in patients with NF1 is bilateral or unilateral renal artery stenosis.
Case report: A 16-year-old boy presented with a headache of 4-year duration and was found to be moderately
hypertensive. On physical examination, axillary freckling and multiple café-au-lait spots were revealed over the trunk,
while numerous small nodules were palpable on the limbs. Biopsy of subcutaneous nodule showed neurofibroma. Lisch
nodules were identified on slit-lamp examination and grade I hypertensive retinopathy was present on fundoscopy.
Clinical laboratory investigations revealed that renal and liver function tests, blood cells count, urinalysis, serum
electrolytes, serum levels of renin and aldosterone, and 24-hour urine levels of catecholamines were all within
normal ranges. Abdominal ultrasound and CT were normal. Both kidneys were of normal size. CT angiography
showed right renal artery stenosis (>90%) at the ostium. The final diagnosis of NF1 with right renal artery stenosis
and secondary hypertension was then made. The patient was treated with Procardin (30 mg/d) and improved with a
significant decline in blood pressure. The main outcomes were to control blood pressure without necessarily
proceeding with PTRA. We also present a review of the literature.
Conclusions: NF1 may present with hypertension due to renal artery stenosis in children. All young patients
(<30 year) with hypertension should be clinically screened for secondary causes of hypertension, including NF1,
so that renal revascularization can be offered before permanent end organ damage has occurred. First-line
management using medication alone could be appropriate, keeping the interventional options for when the
patient's condition deteriorates.
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Neurofibromatosis type 1 (NF1), formerly known as
von Recklinghausen’s disease, is an autosomal dominant
disorder with a birth incidence of 1 in 2,500 to 3,000,
independently of ethnicity and gender [1]. The gene re-
sponsible for NF1 is located on chromosome 17q11.2,
and its protein product, neurofibromin, is ubiquitously
expressed at high levels in the nervous system, and
functions as a tumor suppressor.
Diagnosis is usually made on the basis of: 1) café-au-lait
macules; 2) neurofibromas; 3) Lisch nodules of the iris;
4) axillary freckling; 5) optic pathway gliomas; 6) distinctive* Correspondence: fengkai@medmail.com.cn
1Key Laboratory of Endocrinology, Ministry of Health; Department of
Endocrinology, Peking Union Medical College Hospital, Peking Union Medical
College and Chinese Academy of Medical Sciences, Beijing 100730, China
Full list of author information is available at the end of the article
© 2014 Duan et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orbone lesions; and 7) a first-degree relative with NF1 [2].
Other clinical manifestations are abnormalities of the car-
diovascular, gastrointestinal, renal and endocrine systems,
cognitive deficit, and malignancies of the peripheral nerve
sheath and central nervous system [2].
The cardiovascular features of NF1 may include con-
genital heart disease, vasculopathy and hypertension.
Vasculopathies are the second cause of death in NF1
patients [3]. The incidence of hypertension (>95th per-
centile for age and gender) in patients with NF1 is
approximately 16% [4], and is mostly due to renal artery
stenosis in children [5,6], followed by coarctation of the
aorta and pheochromocytomas [2,7,8]. An annual blood
pressure screening and heart examination are therefore
warranted [2]. Any abnormal finding should be investi-
gated with renal arteriography and 24-h urinary excre-
tion of catecholamines and metabolites [9]. Magnetictd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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should be performed only after biochemical findings
are observed [2,9].
The current management of NF1 focuses on symp-
tomatic treatment. Therefore, early diagnosis of renal
artery stenosis is important, because curative treatment
can prevent the adverse consequences of hypertension.
The blood pressure target in NF1 patients should be
<140/90 mmHg [9,10]. Renal angioplasty may be neces-
sary, but may be insufficient to resolve hypertension,
and drugs may be necessary [11-13].
We present and discuss the case of a 16-year old boy
diagnosed with NF1 and unilateral renal artery stenosis.
We focused on the first-line medical management, and
reviewed the literature.
Case presentation
A 16-year-old boy was admitted to the Peking Union
Medical College Hospital in June 2011, and presented
with an intermittent headache of 4-year duration and
was found to be moderately hypertensive. It was his first
lifetime visit to a doctor. On physical examination, axil-
lary freckling and multiple café-au-lait spots ≥5 mm in
size were revealed, spread over the skin of the trunk
(Figure 1), while numerous small nodules ≤1 cm were
palpable in the limbs. The pigmentation was present
when he was born. He was always lean because of low
appetite, and had always achieved poor academic per-
formance. His height was 166 cm (10th to 25th percent-
ile for same age and gender [14]), weight was 43 kg and
body mass index (BMI) was 15.6 kg/m2.
Interestingly, his first-degree family history revealed no
case of hypertension, cardiovascular diseases or NF1. Bi-
opsy of a subcutaneous nodule resulted in diagnosis of
a neurofibroma, which was confirmed by S100 protein
immunoreactivity of many tumor cells (Figure 2). Lisch
nodules were identified on slit-lamp examination and
grade I hypertensive retinopathy was present on fundos-
copy. All peripheral pulses were palpable and bloodFigure 1 The special signs of the patient. Axillary freckling (a) and multpressure was recorded in all four limbs using a mercury
sphygmomanometer (three times, and using the mean):
right arm = 150/100 mmHg, left arm = 150/95 mmHg,
right leg = 175/120 mmHg and left leg = 170/115 mmHg.
According to the 2010 blood pressure reference standard
in Chinese children and adolescents, the 95th and 99th
percentile of SBP (Systolic Blood Pressure) for 16-year
old boys are 130 mmHg and 141 mmHg, and the 95th
and 99th percentile of DBP (Diastolic Blood Pressure)
are 85 mmHg and 91 mmHg [15].
Clinical laboratory investigations revealed that renal
and liver function tests, blood cell counts, urinalysis,
serum electrolytes, serum levels of renin and aldoster-
one, and 24-h urine levels of catecholamines were all
within normal ranges. Peripheral blood renin level was
0.34 ng/ml/h measured in the supine position, and
1.56 ng/ml/h measured in the standing position.
Ultrasound examination of the abdomen was normal.
Both kidneys were of normal size (the right kidney was
10.1 × 4.0 × 4.1 cm and the left kidney was 11.3 × 3.9 ×
3.8 cm; cortical thickness was 0.6 cm for the right kid-
ney, and 0.5 cm for the left). Abdominal CT did not
show any adrenal or abdominal mass. CT angiography
showed right renal artery stenosis (>90%) at the ostium,
but also that there was collateral circulation from the
subphrenic artery (Figure 3). Blood flow was 36.7 ml/
minute in the right renal, and 57.1 ml/minute in the
left. The final diagnosis of NF1 with right renal artery
stenosis and secondary hypertension was then made.
The patient was treated with oral nifedipine sustained-
release preparation (30 mg once a day), and improved
with a significant decline in blood pressure (120 to 140/
80 to 90 mmHg) after one week. Because: 1) the patient
was young; 2) the right renal size was approximately
normal; 3) the mild decrease in right renal blood flow
was attributable to the collateral circulation; 4) the nor-
mal renin levels; and 5) improvements in blood pressure
using drugs, the patient and his parents refused percu-
taneous transluminal renal angioplasty (PTRA) at thisiple caféau-lait spots (b) spread over the skin of the trunk.
Figure 2 Pathology result of subcutaneous nodules. (a) Hematoxylin and eosin (HE) staining of subcutaneous nodules revealed the diagnosis
of neurofibroma accompanied by mucinous degeneration (magnification × 40). (b) Immunohistochemistry staining for S-100 protein was
positive (magnification × 40).
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hospital after 1 month. The nifedipine treatment was
continued and the patient was simply followed up with
close monitoring of blood pressure, and renal function
at least once every three months in our outpatient
department. PTRA was kept as an option should the
patient's condition deteriorate. Blood pressure was well-
controlled during one year follow-up. The patient was
lost to follow up after one year.
Discussion
We reported the case of a 16-year-old boy who pre-
sented with hypertension. He was diagnosed with NF1
and unilateral renal artery stenosis. Medical treatment
alone improved his condition, and interventional treat-
ment was kept as an option for an eventual deterioration
of his condition. Therefore, medical treatment should be
the initial approach to control hypertension in order to
allow maximal body growth before any intervention.
However, children with sustained hypertension despiteFigure 3 Computed tomography angiography of the renal vessels. Th
was a collateral circulation from the subphrenic artery. Blood flow was 36.7optimal medical management should undergo inter-
vention to avoid the progression of end-organ damage.
Consequently, we monitored his blood pressure, renal
function and renal blood flow.
Renovascular hypertension is an important cause of
secondary hypertension in children, and is responsible
for 3.0% to 8.5% of pediatric hypertension [16,17]. The
most common causes of renovascular hypertension in
children reported in the western literature are fibromuscu-
lar dysplasia (FMD) and midaortic syndrome [16]. How-
ever, Takayasu’s arteritis is the most important cause of
hypertension in Asian children [18]. Renal artery stenosis
may also occur in association with NF1, Williams' syn-
drome, Marfan's syndrome, congenital Rubella syndrome,
Kawasaki disease, and Crohn’s disease [19].
NF1 typically presents with café-au-lait spots, multiple
neurofibroma, axillary freckling, and ocular Lisch nod-
ules [2]. About 16% of patients with NF1 develop hyper-
tension [4], either essential hypertension or secondary
hypertension due to renovascular disease, coarctation ofe initial segment of the right artery was almost occluded, but there
ml/minute in the right renal, and 57.1 ml/minute in the left.
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children and young adults with NF1, the most frequent
cause of hypertension is renovascular disease, which oc-
curs seven times more frequently than pheochromocy-
toma [9]. Renal artery stenosis in NF1 is usually ostial in
location, as was seen in our case [9]. In contrast with
fibromuscular dysplasia where 95% of all stenoses are
found in the distal two-thirds of the renal artery, more
than 50% of all stenoses in NF1 are located at the ostia [9].
Greene et al. originally described two basic categories
of stenosis in NF1. The first involves larger vessels such
as the aorta, carotid and proximal renal arteries, which
are surrounded by neurofibromatosis or ganglioneuro-
matous tissue. Intimal proliferation, thinning of the
media and fragmentation of elastic tissue may lead to
stenosis or aneurysm formation. The second type is
unrelated to neural malformation, but probably reflects
dysplasia of small vessels. Lesions occur in many arteries
and involve the minute intrarenal branches. Using elec-
tron microscopy, Greene et al. identified smooth-muscle
elements within the abnormal cells and concluded that
the vascular lesion is a form of mesodermal dysplasia
[20]. The case presented here probably belongs to the
first category.
Renovascular hypertension results in decreased blood
flow to the kidney, resulting in increased production of
renin. The aim of angioplasty is therefore to restore
blood flow to the kidney, thereby decreasing renin
production [21]. Treatment modalities in renovascular
hypertension secondary to NF1 involve a combination
of drug therapy, PTRA, and surgery [9-13]. Indeed,
Kimura et al. reported good outcomes using renal ar-
tery repair in children, including NF1 patients [12,13].
Malav et al. [6] reported good outcomes using antihyper-
tensive drugs and renal angioplasty, whereas Ueda et al.
[11] and Booth et al. [22] reported persistent high blood
pressure after renal angioplasty. Oderich et al. [3] reported
safe, effective and durable outcomes of surgical manage-
ment of NF1-associated hypertension. However, it is our
opinion that medical treatment should be the initial ap-
proach for controlling hypertension to allow maximal
body growth before any surgical intervention, which is
also advocated by Tullus et al. [21]. However, we agree
that poorly controlled hypertension using medical therapy
is undesirable in children because of the progression of
end-organ damage. A review of 16 NF1 patients with renal
artery stenosis who underwent PTRA had a 33% success
rate with PTRA for primary stenosis. The success rate was
higher (67%) in post-surgery residual stenosis [22]. Be-
cause of the absence of major complications and no ad-
verse effect on subsequent vascular reconstruction, PTRA
should be considered as first-line treatment for renal ar-
tery stenosis in NF1 pediatric patients only when clinically
indicated. In both NF1 and Takayasu’s arteritis, thepresence of ostial stenosis and long-segment disease
predisposes to restenosis. Surgical treatment of renal
artery stenosis by reimplanting the renal artery on the
aorta, or bypassing the obstruction using the saphe-
nous vein or splenic artery, have been reported with
good results [17]. Although restenosis after PTRA is
not uncommon, there are several advantages of PTRA
over surgery. Reduced morbidity from the lack of a
surgical incision and reduced hospital stay are desir-
able at all ages. Furthermore, PTRA does not interfere
with subsequent surgery if it is needed. Stent angio-
plasty is technically successful and can improve hyper-
tension in selected patients. However, arterial stenting
is generally avoided in the pediatric population unless
angioplasty results in a flow-limited dissection, complete
recoil of stenosis, or focal arterial rupture [23].
Han and Criado [24] reviewed 13 papers including 49
patients with NF1 and renovascular hypertension, and
who were treated with medication, surgery, or percutan-
eous transluminal angioplasty (PTA) or coil embolization.
All patients received medical therapy. Eight patients
were treated with medication alone, 10 had a nephrec-
tomy, 13 had surgical revascularization procedures, 16
had a PTA, and 1 patient had transluminal embolization
of an aneurysm. Medication alone improved the condition
of 56% of the patients, but also led to failure in 22%. How-
ever, this rate was similar to the failure rates of surgery
(22%) and PTRA (35%).
In addition to renal artery stenosis, vascular lesions in
NF1 may involve mesenteric vessels, aorta, and cerebral
vessels. NF1 vasculopathy tends to be progressive and
is one of the leading causes of death in this population
[3]. Therefore, careful long-term follow up is therefore
required.Conclusions
NF1 may present with hypertension due to renal artery
stenosis in children. A wider appreciation of this entity
is warranted for early diagnosis and appropriate, prompt
treatment. In summary, NF1 is a disorder usually associ-
ated with bilateral or unilateral renal artery stenosis. All
young patients (<30 years) with hypertension should be
clinically screened very early for secondary causes of
hypertension, including NF1, so that renal revasculariza-
tion can be offered before permanent end-organ damage
has occurred.Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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